Current Paradigms in COVID-19 Research: Proposed Treatment Strategies, Recent Trends and Future Directions
Related Experiment Video
Updated: Dec 15, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Anil K Sharma1, Varruchi Sharma2, Arun Sharma3
1Department of Biotechnology, Maharishi Markandeshwar (Deemed to be University), Mullana-Ambala 133207 Haryana, India.
Background:
Recent pandemic of coronavirus disease caused by a novel coronavirus SARS-CoV-2 in humans is the third outbreak by this family of viruses leading to an acute respiratory infection, which has been a major cause of morbidity and mortality worldwide.The virus belongs to the genus, Betacoronavirus, which has been recently reported to have significant similarity (>89%) to a severe acute respiratory syndrome (SARS)-related member of the Sarbecoviruses. Current researches are not sufficient to understand the etiological and immunopathobiological parameters related to COVID-19 so as to have a therapeutic solution to the problem.
Methods:
A structured search of bibliographic databases for peer-reviewed research literature has been carried out using focused review questions and inclusion/exclusion criteria. Further Standard tools were implied in order to appraise the quality of retrieved papers. The characteristic outcomes of screened research and review articles along with analysis of the interventions and findings of included studies using a conceptual framework have been described employing a deductive qualitative content analysis methodology.
Results:
This review systematically summarizes the immune-pathobiological characteristics, diagnosis, potential therapeutic options for the treatment and prevention of COVID-19 based on the current published literature and evidence. The current review has covered 125 peerreviewed articles, the majority of which are from high-income technically developed countries providing the most recent updates about the current understanding of the COVID-19 bringing all the significant findings and related researches together at a single platform. In addition, possible therapeutic interventions, treatment strategies and vaccine development initiatives to manage COVID-19 have been proposed.
Conclusion:
It is anticipated that this review would certainly assist the public in general and scientific community in particular to recognize and effectively deal with COVID-19, providing a reference guide for futuristic studies.
Insights
This review summarizes current knowledge on coronavirus disease (COVID-19), caused by SARS-CoV-2. It details immune-pathobiological characteristics, diagnosis, and potential treatments to aid the scientific community and public.
Area of Science:
- Virology
- Immunology
- Public Health
Background:
- Coronavirus disease (COVID-19), caused by SARS-CoV-2, is a global health crisis.
- The virus, a Betacoronavirus, shares similarities with SARS-related coronaviruses.
- Existing research is insufficient to fully understand COVID-19's etiology and immunopathobiology for effective treatment.
Purpose of the Study:
- To systematically review and synthesize current literature on COVID-19.
- To consolidate information on immune-pathobiological characteristics, diagnosis, and therapeutic options.
- To provide a reference for future research and public understanding.
Main Methods:
- Structured literature search of bibliographic databases.
- Inclusion/exclusion criteria applied to peer-reviewed research.
- Deductive qualitative content analysis of findings from 125 articles.
Main Results:
- Summarizes immune-pathobiological features, diagnostic methods, and potential treatments for COVID-19.
- Includes recent updates from high-income countries, consolidating significant findings.
- Proposes therapeutic interventions, treatment strategies, and vaccine development initiatives.
Conclusions:
- The review serves as a reference guide for the scientific community and the public.
- Aims to enhance understanding and management of COVID-19.
- Facilitates recognition and effective handling of the pandemic.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Targeted Cancer Therapies
There are several types of targeted therapies against...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Single Nucleotide Polymorphisms-SNPs

